What is the current valuation of the India Allergy Immunotherapy Market?

The market valuation was 113.2 USD Million in 2024. Read More

What is the projected market size for the India Allergy Immunotherapy Market by 2035?

The market is expected to reach 305.08 USD Million by 2035. Read More

What is the expected CAGR for the India Allergy Immunotherapy Market during the forecast period?

The expected CAGR for the market from 2025 to 2035 is 9.43%. Read More

Which application segment has the highest valuation in the India Allergy Immunotherapy Market?

The Allergic Rhinitis segment had a valuation range of 45.0 to 120.0 USD Million. Read More

Which patient demographic segment shows the highest market potential?

The Adult Patients segment had a valuation range of 60.0 to 160.0 USD Million. Read More

What is the valuation range for the Intranasal Immunotherapy segment?

The Intranasal Immunotherapy segment is valued between 38.2 and 105.08 USD Million. Read More

Who are the leading players in the India Allergy Immunotherapy Market?

Key players include Allergan, Boehringer Ingelheim, Merck Group, and Novartis. Read More

What is the valuation range for the Long-term Treatment segment?

The Long-term Treatment segment is valued between 30.0 and 80.0 USD Million. Read More

How does the market for Food Allergy immunotherapy compare to other segments?

The Food Allergy segment had a valuation range of 10.0 to 25.0 USD Million, indicating lower market potential compared to others. Read More

India Allergy Immunotherapy Market

Q: What are the key types of immunotherapy in the India Allergy Immunotherapy Market?

The key types include Subcutaneous Immunotherapy, Sublingual Immunotherapy, Oral Immunotherapy, and Intranasal Immunotherapy. Read More

ID: MRFR/HC/54531-HCR

200 Pages

Nidhi Mandole

Last Updated: May 12, 2026

India Allergy Immunotherapy Market Research Report: By Type (Subcutaneous Immunotherapy, Sublingual Immunotherapy, Oral Immunotherapy), By Product (Allergen Extracts, Conventional Immunotherapy, Biologics), By Indication (Allergic Rhinitis, Allergic Asthma, Atopic Dermatitis, Food Allergies) andBy Patient Type (Pediatric, Adult, Geriatric)- Forecast to 2035

India Allergy Immunotherapy Market Infographic

Summary Table of Contents Segmentation Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 India Allergy Immunotherapy Market, BY Application (USD Million) | |
  1. 4.1.1 Allergic Rhinitis | |
  2. 4.1.2 Allergic Asthma | |
  3. 4.1.3 Insect Allergy | |
  4. 4.1.4 Food Allergy | |
  5. 4.1.5 Atopic Dermatitis |
2. 4.2 India Allergy Immunotherapy Market, BY Type of Immunotherapy (USD Million) | |
  1. 4.2.1 Subcutaneous Immunotherapy | |
  2. 4.2.2 Sublingual Immunotherapy | |
  3. 4.2.3 Oral Immunotherapy | |
  4. 4.2.4 Intranasal Immunotherapy |
3. 4.3 India Allergy Immunotherapy Market, BY Patient Demographics (USD Million) | |
  1. 4.3.1 Pediatric Patients | |
  2. 4.3.2 Adult Patients | |
  3. 4.3.3 Geriatric Patients | |
  4. 4.3.4 Gender-based Segmentation |
4. 4.4 India Allergy Immunotherapy Market, BY Treatment Duration (USD Million) | |
  1. 4.4.1 Short-term Treatment | |
  2. 4.4.2 Long-term Treatment | |
  3. 4.4.3 Maintenance Treatment | |
  4. 4.4.4 Induction Treatment 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the India Allergy Immunotherapy Market | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the India Allergy Immunotherapy Market | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Allergan (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Boehringer Ingelheim (DE) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Merck Group (DE) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Novartis (CH) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Stallergenes Greer (GB) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Aimmune Therapeutics (US) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 ALK-Abello (DK) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 HollisterStier Allergy (US) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 INDIA MARKET ANALYSIS BY APPLICATION |
6. 6.3 INDIA MARKET ANALYSIS BY TYPE OF IMMUNOTHERAPY |
7. 6.4 INDIA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS |
8. 6.5 INDIA MARKET ANALYSIS BY TREATMENT DURATION |
9. 6.6 KEY BUYING CRITERIA OF INDIA ALLERGY IMMUNOTHERAPY MARKET |
10. 6.7 RESEARCH PROCESS OF MRFR |
11. 6.8 DRO ANALYSIS OF INDIA ALLERGY IMMUNOTHERAPY MARKET |
12. 6.9 DRIVERS IMPACT ANALYSIS: INDIA ALLERGY IMMUNOTHERAPY MARKET |
13. 6.10 RESTRAINTS IMPACT ANALYSIS: INDIA ALLERGY IMMUNOTHERAPY MARKET |
14. 6.11 SUPPLY / VALUE CHAIN: INDIA ALLERGY IMMUNOTHERAPY MARKET |
15. 6.12 INDIA ALLERGY IMMUNOTHERAPY MARKET, BY APPLICATION, 2024 (% SHARE) |
16. 6.13 INDIA ALLERGY IMMUNOTHERAPY MARKET, BY APPLICATION, 2024 TO 2035 (USD Million) |
17. 6.14 INDIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF IMMUNOTHERAPY, 2024 (% SHARE) |
18. 6.15 INDIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF IMMUNOTHERAPY, 2024 TO 2035 (USD Million) |
19. 6.16 INDIA ALLERGY IMMUNOTHERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2024 (% SHARE) |
20. 6.17 INDIA ALLERGY IMMUNOTHERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2024 TO 2035 (USD Million) |
21. 6.18 INDIA ALLERGY IMMUNOTHERAPY MARKET, BY TREATMENT DURATION, 2024 (% SHARE) |
22. 6.19 INDIA ALLERGY IMMUNOTHERAPY MARKET, BY TREATMENT DURATION, 2024 TO 2035 (USD Million) |
23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
24. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
25. 7.2 India MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY APPLICATION, 2026-2035 (USD Million) | |
  2. 7.2.2 BY TYPE OF IMMUNOTHERAPY, 2026-2035 (USD Million) | |
  3. 7.2.3 BY PATIENT DEMOGRAPHICS, 2026-2035 (USD Million) | |
  4. 7.2.4 BY TREATMENT DURATION, 2026-2035 (USD Million) |
26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.3.1 |
27. 7.4 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

India Allergy Immunotherapy Market Segmentation

India Allergy Immunotherapy Market By Application (USD Million, 2022-2035)

Allergic Rhinitis
Allergic Asthma
Insect Allergy
Food Allergy
Atopic Dermatitis

India Allergy Immunotherapy Market By Type of Immunotherapy (USD Million, 2022-2035)

Subcutaneous Immunotherapy
Sublingual Immunotherapy
Oral Immunotherapy
Intranasal Immunotherapy

India Allergy Immunotherapy Market By Patient Demographics (USD Million, 2022-2035)

Pediatric Patients
Adult Patients
Geriatric Patients
Gender-based Segmentation

India Allergy Immunotherapy Market By Treatment Duration (USD Million, 2022-2035)

Short-term Treatment
Long-term Treatment
Maintenance Treatment
Induction Treatment

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓